Effect of l-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats

Neurotoxicity Research

Volumn 23, Issue 4, 2013, Pages 327-335

  Ferreira, Gabriela K ^a,b   Scaini, Giselli ^a,b   Carvalho Silva, Milena ^a,b   Gomes, Lara M ^a,b   Borges, Lislaine S ^a,b   Vieira, Júlia S ^a,b   Constantino, Larissa S ^a,b   Ferreira, Gustavo C ^a   Schuck, Patrícia F ^a   Streck, Emilio L ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Brain; Energy metabolism; Liver; Tyrosine; Tyrosinemia type II

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; MALATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); TYROSINE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DECAPITATION; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; JUVENILE ANIMAL; LIVER; MALE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; TYROSINEMIA; WISTAR RAT;

AGE FACTORS; ANIMALS; BRAIN; ENERGY METABOLISM; LIVER; MALE; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; RATS; RATS, WISTAR; TYROSINE;

RATTUS; RATTUS NORVEGICUS;

EID: 84876293983     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-012-9345-4     Document Type: Article

References (47)

1. Adam-Vizi V (2005) Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 7:1140-1149
2. Boekema EJ, Braun HP (2007) Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Chem Biol 28:1-4
3. Bongiovanni R, Yamamoto BK, Simpson C, Jaskiw GE (2003) Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat. J Neurochem 87:310-317
4. Brennan WA, Bird ED, Aprille JR (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 44:1948-1950
5. Cadenas E, Davies KJA (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222-230
6. Carbonell T, Rama R (2007) Oxidative stress and early neurological deterioration in ischemic stroke. Curr Med Chem 14:857-874
7. Cassina A, Radi R (1996) Differential inhibitory Action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328:309-316
8. Corrêa C, Amboni G, Assis LC, Martins MR, Kapczinski F, Streck EL, Quevedo J (2007) Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 31:887-891
9. D'Eufemia P, Finocchiaro R, Celli M, Raccio I, Properzi E, Zicari A (2009) Increased nitric oxide release by neutrophils of a patient with tyrosinemia type III. Biomed Pharmacother 63:359-361
10. Dawson TM, Gonzalez-Zulueta M, Kusel J, Dawson VL (1998) Nitric oxide: diverse actions in the central and peripheral nervous systems. Neuroscientist 4:96-112
11. de Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2011) Tyrosine inhibits creatine kinase activity in cerebral cortex of young rats. Metab Brain Dis 26:221-227
12. de Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2012) Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats. Mol Cell Biochem 364:253-261
13. Deng H, Hu H, Fang Y (2012) Multiple tyrosine metabolites are GPR35 agonists. Sci Rep 2:373
14. Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23-26
15. García-Cazola A, Wolf IN, Serrano M, Moog U, Perez-Dueñas B, Póo P, Pineda M, Campistol J, Hoffmann GF (2009) Mental retardion and inborn errors of metabolism. J Inherit Metab Dis 32:599-608
16. Goldsmith LA, Kang E, Bienfang DC, Jimbow K, Gerald P, Baden HP (1973) Tyrosinemia with plantar and palmar keratosis and keratitis. J Pediatr 83:798-805
17. Halliwell B, Gutteridge JM (2007) Free radicals in biology and medicine. Oxford University Press, New York
18. Heales SJ, Bolanõs JP, Stewart VC, Brookes PS, Land JM, Clark JB (1999) Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410:215-228
19. Held PK (2006) Disorders of tyrosine catabolism. Mol Genet Metab 88:103-106
20. Jana S, Sinha M, Chanda D, Roy T, Banerjee K, Munshi S, Patro BS, Chakrabarti S (2011) Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease. Biochim Biophys Acta 1812:663-673
21. Kelly D, Gordon J, Alpers R, Strauss AW (1989) The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem 264:18921-18925
22. Kitto GB (1969) Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Methods Enzymol XIII:106-116
23. Lemonnier F, Charpentier C, Odievre M, Larregue M, Lemonnier A (1979) Tyrosine aminotransferase isoenzyme deficiency. J Pediatr 94:931-932
24. Llesuy SF, Milei J, Molina H, Boveris A, Milei S (1985) Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4'-epiadriamycin in mice. Tumori 71:241-249
25. Lowry OH, Rosebough NG, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
26. Macsai MS, Schwartz TL, Hinkle D, Hummel MB, Mulhern MG, Rootman D (2001) Tyrosinemia type II: nine cases of ocular signs and symptoms. Am J Ophthalmol 132:522-527
27. Mitchell GA, Grompe M, Lambert M, Tanguay RM (2001) Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1977-1982
28. Monsalve M, Borniquel S, Valle I, Lamas S (2007) Mitochondrial dysfunction in human pathologies. Front Biosci 12:1131-1153
29. Moreira PI, Santos MS, Oliveira CR (2007) Alzheimer's disease: a lesson from mitochondrial dysfunction. Antioxid Redox Signal 9:1621-1630
30. Morelli A, Ravera S, Panfoli I (2011) Hypothesis of an energetic function for myelin. Cell Biochem Biophys 61:179-187
31. Morre MC, Hefti F, Wurtman RJ (1980) Regional tyrosine levels in rat brain after tyrosine administration. J Neural Transm 49:45-50
32. Nakamura K, Tanaka Y, Mitsubuchi H, Endo F (2007) Aninal models of tyrosinemia. J Nutr 137:1557-1560
33. Peng ZF, Chen MJ, Yap YW, Manikandan J, Melendez AJ, Choy MS, Moore PK, Cheung NS (2008) Proteasome inhibition: an early or late event in nitric oxide-induced neuronal death? Nitric Oxide 18:136-145
34. Rabinowitz LG, Williams LR, Anderson CE, Mazur A, Kaplan P (1995) Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. J Pediatr 126:266-269
35. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35-51
36. Schurr A (2002) Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem Int 41:1-8
37. Scott CR (2006) The genetic tyrosinemias. Am J Med Genet C Semin Med Genet 142:121-126
38. Sener RN (2005) Brain magnetic resonance imaging in tyrosinemia. Acta Radiol 46:618-620
39. Sgaravatti AM, Vargas BA, Zandoná BR, Deckmann KB, Rockenback FJ, Moraes TB, Monserrat JM, Sgarbi MB, Pederzolli CD, Wyse ATS, Wannmacher CMD, Wajner M, Dutra-Filho CS (2008) Tyrosine promotes oxidative stress in cerebral cortex of young rats. Int J Dev Neurosci 26:553-559
40. Sgaravatti AM, Magnusson AS, de Oliveira AS, Rosa AP, Mescka CP, Zanin FR, Pederzolli CD, Wyse AT, Wannmacher CM, Wajner M, Dutra-Filho CS (2009) Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex. Metab Brain Dis 24:415-425
41. Shepherd D, Garland PB (1969) The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J 114:597-610
42. Shrimpton AE, Braddock BR, Thomson LL, Stein CK, Hoo JJ (2004) Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype. Clin Genet 66:537-544
43. Stoerner JW, Butler IJ, Morriss FH Jr, Howell RR Jr, Seifert WE Jr, Caprioli RM, Adcock EW, Denson SE (1980) CSF neurotransmitter studies. An infant with ascorbic acid-responsive tyrosinemia. Am J Dis Child 134:492-494
44. Tyler D (1992) The mitochondrion in health and diseases. VCH, New York
45. Valikhani M, Akhyani M, Jafari AK, Barzegari M, Toosi S (2005) Oculocutaneous tyrosinaemia or tyrosinaemia type 2: a case report. J Eur Acad Dermatol Venereol 20:591-594
46. Vincent VA, Tilders FJ, Van Dam AM (1998) Production, regulation and role of nitric oxide in glial cells. Mediators Inflamm 7:239-255
47. Wajner M, Latini A, Wyse ATS, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metabolic Dis 27:427-448